Samarut C, Revillard J P
Eur J Immunol. 1979 May;9(5):415-20. doi: 10.1002/eji.1830090513.
The capacity of human peripheral blood lymphocytes to bind antigen-IgG or antigen-IgM-antibody complexes was investigated using a rosette technique with ox erythrocytes (E) coated with rabbit IgG (AG) or IgM (AM) antibodies. EAM rosette formation was achieved only in suspensions pre-incubated for 24 h at 37 degrees C. Addition of either EAM or EAG complexes to the culture medium was shown to prevent the formation of EAM rosettes. The inhibition was reversible, it was not due to trace IgM contaminants in the IgG antibody fraction. It was not observed when lymphocytes depleted of EAG-rosetting cells were incubated with EAG complexes. Inhibition of the expression of lymphocyte receptors for IgM can be regarded as a consequence of the modulation of surface receptors for IgG and involves an interaction between the two lymphocyte subsets bearing surface receptors for IgG and IgM, respectively. However, these experiments do not exclude the possibility that a few cells which bind EAG may lose their receptors by modulation and then express a receptor for IgM.
采用兔IgG(AG)或IgM(AM)抗体包被的牛红细胞(E)玫瑰花结技术,研究了人外周血淋巴细胞结合抗原-IgG或抗原-IgM抗体复合物的能力。仅在37℃预孵育24小时的悬浮液中才能形成EAM玫瑰花结。向培养基中添加EAM或EAG复合物均能阻止EAM玫瑰花结的形成。这种抑制作用是可逆的,并非由于IgG抗体组分中存在微量IgM污染物所致。当将耗尽EAG玫瑰花结形成细胞的淋巴细胞与EAG复合物孵育时,未观察到抑制现象。IgM淋巴细胞受体表达的抑制可被视为IgG表面受体调节的结果,并且涉及分别带有IgG和IgM表面受体的两个淋巴细胞亚群之间的相互作用。然而,这些实验并未排除少数结合EAG的细胞可能通过调节失去其受体然后表达IgM受体的可能性。